Accra: Mrs. Olivia Agyekumwaa Boateng, Head of Tobacco and Substance Abuse Department of the Food and Drugs Authority (FDA), has called for youth-led agencies to partner with the Authority in a concerted effort to combat drug abuse in the country. This initiative primarily targets the misuse of substances such as Tramadol, Tapentadol, and emerging drugs like 'RED' among the youth.

According to Ghana News Agency, the appeal was made during the launch of the 'Ghana Against Drugs - 'Red Means Stop'' campaign, a national youth anti-drug initiative by the Ministry of Youth Development and Empowerment. The campaign seeks to address the escalating issue of substance abuse among the youth in Ghana. Mrs. Boateng emphasized the severe health risks associated with the misuse of opioids such as Tapentadol, particularly when combined with depressants like alcohol, which can lead to life-threatening situations including respiratory depression, coma, or death.

Mrs. Boateng highlighted the FDA's commitment as the regulatory body responsible for public health in Ghana, working through stringent regulatory measures and collaborations with stakeholders to address drug abuse issues. The FDA, in cooperation with state agencies like the Ghana Revenue Authority, Narcotics Control Commission, Ghana Police Service, and Pharmacy Council, is actively conducting surveillance, seizing illicit drugs, and imposing sanctions on offenders.

She further raised concerns about the global opioid crisis reaching West Africa, with increasing reports of substance abuse involving fentanyl, pethidine, Tapentadol, and tramadol. Studies have indicated a 'tramadol crisis' in the sub-region, with significant use among the youth linked to various hardships.

The FDA has identified a surge in the illegal importation and distribution of unregistered opioids, often smuggled into Ghana and sold through unauthorized channels. Mrs. Boateng noted that many of these drugs are transit goods finding their way into the country, thus posing a significant public health risk.

In its efforts to promote responsible use of controlled substances and prevent opioid abuse, the FDA remains steadfast in its commitment to safeguarding public health and ensuring the safety of regulated products across Ghana.